about
Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardiaRelationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-induced Aortic FibrosisResearch ethics consultation: an attempt and 5-year experience in a Japanese University HospitalPharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting databaseRelationship between the administration of nicardipine hydrochloride and the development of delirium in patients on mechanical ventilationAssociation Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective StudyIrinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting databaseDevelopment and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levelsNitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm FormationResponse to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not
P50
Q39194479-9962DBAA-0955-4E85-BE44-0335C1229071Q42036019-F6D9C069-0A69-46CA-B8E4-AE2C6433605DQ47863692-390D4D80-7876-4E2D-95F7-38A883B4662DQ57795338-1022A834-2BB8-42EC-A9A8-56687AC7999EQ58657049-1D477BB2-431B-4384-A5B8-76D417B7DC01Q61443958-E68DD705-DF86-48DD-991A-3EAF14AED710Q90313236-90B99FCC-73A9-4B25-9440-4BC7A76A4E92Q90350169-D63B3F3F-CC88-4E1D-9C10-BEF860059C81Q90655827-930C5261-9703-44FA-9296-E835A6C11B9AQ91475867-FBF7D1A9-B17A-4007-8788-BAF836D7160EQ91729517-B302533D-504B-438A-B8EF-92447AD3F3EBQ92160212-AA52F011-FD60-4A4C-B555-CD04E428BBA4
P50
description
researcher
@en
name
Masayuki Chuma
@en
type
label
Masayuki Chuma
@en
prefLabel
Masayuki Chuma
@en
P31
P496
0000-0002-5755-283X